mediwales
DESCRIPTION
MediWales. June 2014. IP Group Share Price. Gold. The FTSE All Share Index. A house in Cardiff. £325. £171. £234. £330. Traditional US Life Science Venture Performance. Looking at it in a different way……. Source: Nesta. UK Private Equity and Venture Returns 1996:2012. - PowerPoint PPT PresentationTRANSCRIPT
MediWales
June 2014
2
Gold
IP Group Share Price
The FTSE All Share Index
A house in Cardiff
3
£171
£234
£325
£330
4© IP Group plc 2014
Traditional US Life Science Venture Performance
19721979
19811983
19851987
19891991
19931995
19971999
20012003
20052007
-20
-10
0
10
20
30
40
50US VC returns by vintage year
% IR
RLooking at it in a different way……
Source: Nesta
6© IP Group plc 2014
Venture Small MBO Mid MBO Large MBO
0.4%
16.0%
12.3%
14.7%
UK Private Equity and Venture Returns 1996:2012
Source: PwC BVCA Private Equity and Venture Capital Performance Measurement Survey 2012
© IP Group plc 2014
UK scientists awarded over 70 Nobel Prizes
Rated as best Euro location for bioscience, healthcare / medical and clinical research
Is the leading the G8 for research productivity
The UK has 31 of the worlds top 200 Universities
Four of the world’s top ten universities for life sciences are in the UK
The UK has a world class Life Science Sector
7
Glasgow
Nottingham
Oxford
Manchester
Cambridge
Kings / Cambridge
8
“Post-seed”Incubation SeedDisclosures
100% 3% 1.5% 1%
Stage of development
Aim to deploy as little capital as possible
Aim to increase level of capital
deployed as risk profile reduces
Exclusive access to IP from leading research
universities
Incubate and test with as little cash as possible
1 2 Back the winners with cash and people
3
Business Model
30% 70%
© IP Group plc 20149
© IP Group plc 201410
11© IP Group plc 2014
No of com-panies
Gross invested
Value
£72m
£122m
£328m
Portfolio track record – IP Group
© IP Group plc 2014
Acquisition of Fusion IP plc and £100M placing
12
© IP Group plc 2014
Healthcare IT
13
Small Molecule TherapeuticsRegenerative Medicine
Medical Devices
Personalised Medicine:Biomarkers and Diagnostics
SAW Diagnostics
E-tect
Drug Discovery Products and Services
Life Science Instrumentation
Vaccines and Biologics
Life Science Portfolio
Oxsybio
14
Why there is so much excitement around ONT
From the mainframe To the laptop To the USB stick
“We will be telling our grandchildren that we used to do sequencing in specialist buildings with big machines – they’ll never believe us”
“This represents the democratisation of sequencing”
15
Tissue Regenix Group plc
Regenerative common body soft tissue parts
Heart valves
Vascular grafts
Dialysis access
Meniscus
Vascular patch
Shoulder (rotator cuff)
Bladder
Cardiac patch
Bypass graft
Knee ligament (cruciate)
Blood vessels Ankle
Successful IPO in June 2010 Significant press coverage
Advanced woundcare product DermaPure reimbursement approved in the US
Additional programmes in Cardiac, Orthopaedics and Vascular
Going from strength to strength
16
Medaphor Limited
Bye-bye mannequins Sales!
Saves time, money and resources for hospitals and training centres, Cross-application potential
100 Systems sold globally to date
Virtual reality ultrasound training in a growing market
17
Asalus Medical Instruments Limited
Disruptive in a £300M market
Based on electrostatic precipitation, a highly effective means of removing airborne particulates
Recently CE marked and now available in 15 countries
£4M in equity financing to date
The ProblemSurgical smoke is a
significant issue during laparoscopic surgery
Winners of the Cutlers’ Surgical Prize and Praxis
Unico award
MediWales
June 2014